{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:53:26Z","timestamp":1787770406063,"version":"build-2784847793"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijrobp.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T02:30:15Z","timestamp":1506047415000},"page":"825-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee"],"prefix":"10.1016","volume":"99","author":[{"given":"Yolanda D.","family":"Tseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul R.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Cahlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Chuong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dedeckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad K.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Yn","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Yi-Liang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Terezakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahed N.","family":"Badiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia M.","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy P.","family":"Mendenhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Pankuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Flampouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradford S.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.05.004_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1148\/110.2.445","article-title":"Proton radiation therapy","volume":"110","author":"Archambeau","year":"1974","journal-title":"Radiology"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib2","series-title":"Model policies: Proton beam therapy (PBT)","year":"2014"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib3","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose-volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib4","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","article-title":"Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger","volume":"20","author":"Ng","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib5","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin's disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib6","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1182\/blood-2010-04-278796","article-title":"Morbidity and mortality in long-term survivors of Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study","volume":"117","author":"Castellino","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib7","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin's lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","article-title":"Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease","volume":"94","author":"Travis","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1667\/0033-7587(2003)159[0161:LCATFH]2.0.CO;2","article-title":"Lung cancer after treatment for Hodgkin's disease: Focus on radiation effects","volume":"159","author":"Gilbert","year":"2003","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib11","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.3324\/haematol.2014.108258","article-title":"Risk of esophageal cancer following radiotherapy for Hodgkin lymphoma","volume":"99","author":"Morton","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib12","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1200\/JCO.2013.50.6832","article-title":"Stomach cancer risk after treatment for Hodgkin lymphoma","volume":"31","author":"Morton","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib13","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/annonc\/mdu287","article-title":"Pancreatic cancer risk\u00a0after treatment of Hodgkin lymphoma","volume":"25","author":"Dores","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib14","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1001\/jama.1993.03510160067031","article-title":"Factors affecting late mortality from heart disease after treatment of Hodgkin's disease","volume":"270","author":"Hancock","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv008","article-title":"Risk of valvular heart disease after treatment for Hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib18","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: Effects of cardiac exposure to radiation and anthracyclines","volume":"129","author":"van Nimwegen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib19","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1200\/JCO.2005.15.107","article-title":"Stroke as a late treatment effect of Hodgkin's disease: A report from the Childhood Cancer Survivor Study","volume":"23","author":"Bowers","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib20","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/jnci\/djp147","article-title":"Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma","volume":"101","author":"De Bruin","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib21","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/annonc\/mdn284","article-title":"A prospective study of pulmonary function in Hodgkin's lymphoma patients","volume":"19","author":"Ng","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib22","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.2013.54.4379","article-title":"Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma","volume":"32","author":"van Nimwegen","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib23","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.ijrobp.2010.09.054","article-title":"Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma","volume":"82","author":"Cella","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2010.02.004","article-title":"Radiation therapy and late mortality from second sarcoma, carcinoma, and hematological malignancies after a solid cancer in childhood","volume":"80","author":"Tukenova","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib25","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/jnci\/djj411","article-title":"New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study","volume":"98","author":"Neglia","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib26","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ijrobp.2012.06.006","article-title":"Risk of salivary gland cancer after childhood cancer: A report from the Childhood Cancer Survivor Study","volume":"85","author":"Boukheris","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1667\/RR2240.1","article-title":"Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: An update from the Childhood Cancer Survivor Study","volume":"174","author":"Bhatti","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib28","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/j.ijrobp.2011.05.069","article-title":"Second malignant neoplasms in digestive organs after childhood cancer: A cohort-nested case-control study","volume":"82","author":"Tukenova","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib29","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/cncr.30200","article-title":"Risk and impact of pulmonary complications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study","volume":"122","author":"Dietz","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib30","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","article-title":"Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma","volume":"25","author":"Hodgson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib31","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib32","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes","volume":"27","author":"De Bruin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib33","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.2011.38.8835","article-title":"Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: A National Cohort Study","volume":"30","author":"Swerdlow","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib34","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1002\/cncr.26257","article-title":"Survival after second primary lung cancer: A population-based study of 187 Hodgkin lymphoma patients","volume":"117","author":"Milano","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib35","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/cncr.23918","article-title":"Risk of radiation-related salivary gland carcinomas among survivors of Hodgkin lymphoma: A population-based analysis","volume":"113","author":"Boukheris","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2015.11.046","article-title":"Radiation-related new primary solid cancers in the Childhood Cancer Survivor Study: Comparative radiation dose response and modification of treatment effects","volume":"94","author":"Inskip","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib37","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1667\/RR14213.1","article-title":"Thyroid cancer after childhood exposure to external radiation: An updated pooled analysis of 12 studies","volume":"185","author":"Veiga","year":"2016","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib38","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/jnci\/85.23.1932","article-title":"Second cancers among long-term survivors of non-Hodgkin's lymphoma","volume":"85","author":"Travis","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/cncr.21971","article-title":"The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma","volume":"107","author":"Tward","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2141.2011.08713.x","article-title":"Review of the cardiac long-term effects of therapy for Hodgkin lymphoma","volume":"154","author":"Ng","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib41","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","article-title":"Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study","volume":"99","author":"Swerdlow","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib42","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1470-2045(16)30215-7","article-title":"Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: An analysis from the St Jude Lifetime Cohort Study","volume":"17","author":"Bhakta","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib43","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib44","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","article-title":"Cardiovascular disease after treatment for Hodgkin's lymphoma: An analysis of nine collaborative EORTC-LYSA trials","volume":"2","author":"Maraldo","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2011.05.078","article-title":"Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy","volume":"83","author":"Fox","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2015.02.010","article-title":"Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma","volume":"92","author":"Pinnix","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib47","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/cncr.10978","article-title":"Pulmonary complications in survivors of childhood and adolescent cancer. A report from the Childhood Cancer Survivor Study","volume":"95","author":"Mertens","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s002770050565","article-title":"Thyroid toxicity of treatment for Hodgkin's disease","volume":"79","author":"Bethge","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib49","first-page":"3227","article-title":"Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study","volume":"85","author":"Sklar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(95)91461-7","article-title":"Diabetes mellitus after abdominal radiation therapy","volume":"346","author":"Teinturier","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib51","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archinternmed.2009.209","article-title":"Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: A report for the Childhood Cancer Survivor Study","volume":"169","author":"Meacham","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib52","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(12)70323-6","article-title":"Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: A retrospective cohort study","volume":"13","author":"de Vathaire","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib53","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2011.12.034","article-title":"Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma","volume":"84","author":"Hoppe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib54","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.ijrobp.2014.04.029","article-title":"Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: Results of a phase 2 study","volume":"89","author":"Hoppe","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib55","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.ijrobp.2008.12.048","article-title":"Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy","volume":"75","author":"Chera","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00066-012-0235-8","article-title":"Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?","volume":"189","author":"Knausl","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1748-717X-8-22","article-title":"Hodgkin's lymphoma emerging radiation treatment techniques: Trade-offs between late radio-induced toxicities and secondary malignant neoplasms","volume":"8","author":"Cella","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib58","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canrad.2015.11.002","article-title":"Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy","volume":"20","author":"Horn","year":"2016","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib59","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/j.ijrobp.2011.01.061","article-title":"Dosimetric comparison of involved-field three-dimensional conformal photon radiotherapy and breast-sparing proton therapy for the treatment of Hodgkin's lymphoma in female pediatric patients","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.radonc.2013.09.027","article-title":"Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy","volume":"110","author":"Maraldo","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib61","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/0284186X.2016.1191665","article-title":"Proton pencil beam scanning for mediastinal lymphoma: Treatment planning and robustness assessment","volume":"55","author":"Zeng","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib62","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"24","author":"Maraldo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijrobp.2010.05.007","article-title":"Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma","volume":"81","author":"Li","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib64","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3109\/0284186X.2013.813636","article-title":"The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma","volume":"52","author":"J\u00f8rgensen","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib65","doi-asserted-by":"crossref","first-page":"5386","DOI":"10.1120\/jacmp.v16i5.5386","article-title":"Late radiation toxicity in Hodgkin lymphoma patients: Proton therapy's potential","volume":"16","author":"Toltz","year":"2015","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib66","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3109\/10428194.2014.975802","article-title":"Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma","volume":"56","author":"Sachsman","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib67","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijrobp.2013.06.004","article-title":"Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: Is stroke still a late effect of treatment?","volume":"87","author":"Maraldo","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib68","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1748-717X-9-94","article-title":"Dosimetric advantages of a \u201cbutterfly\u201d technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma","volume":"9","author":"Voong","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib69","doi-asserted-by":"crossref","first-page":"492","DOI":"10.14338\/IJPT-17-00012","article-title":"Comparing breath hold and free breathing during intensity-modulated radiation therapy and proton therapy in patients with mediastinal Hodgkin lymphoma","volume":"3","author":"Hoppe","year":"2017","journal-title":"Int J Particle Ther"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib70","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00066-014-0719-9","article-title":"Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma: When should they be considered and which questions remain open?","volume":"190","author":"Lohr","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijrobp.2015.09.043","article-title":"In the battle between protons and photons for hematologic malignancies, the patient must win","volume":"95","author":"Dabaja","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib72","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3109\/0284186X.2013.765966","article-title":"Proton therapy in a pediatric patient with stage III Hodgkin lymphoma","volume":"52","author":"Holtzman","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","article-title":"Minimizing late effects for patients with mediastinal Hodgkin lymphoma: Deep inspiration breath-hold, IMRT, or both?","volume":"92","author":"Aznar","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib74","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ijrobp.2011.05.015","article-title":"Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin's lymphoma","volume":"82","author":"Paumier","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib75","doi-asserted-by":"crossref","first-page":"E458","DOI":"10.1016\/j.ijrobp.2015.07.1717","article-title":"Proton therapy versus IMRT for mediastinal lymphoma with and without breath hold","volume":"93","author":"Rechner","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib76","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/pbc.26044","article-title":"Proton therapy for pediatric Hodgkin lymphoma","volume":"63","author":"Wray","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib77","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1080\/0284186X.2016.1197422","article-title":"Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: Results from the Proton Collaborative Group Registry","volume":"55","author":"Hoppe","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib78","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx287","article-title":"The use of consolidative proton therapy after first-line therapy among patients with Hodgkin lymphoma at academic and community proton centers","author":"Hoppe","year":"2017","journal-title":"Ann Oncol"},{"issue":"Suppl","key":"10.1016\/j.ijrobp.2017.05.004_bib79","doi-asserted-by":"crossref","first-page":"E461","DOI":"10.1016\/j.ijrobp.2015.07.1725","article-title":"Proton therapy for mediastinal lymphomas: An 8-year single-institution report","volume":"93","author":"Winkfield","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib80","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.3109\/10428194.2015.1014364","article-title":"Proton therapy in the management of non-Hodgkin lymphoma","volume":"56","author":"Sachsman","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib81","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1016\/j.ijrobp.2016.06.1876","article-title":"First clinical report of pencil beam scanned proton therapy for mediastinal lymphoma","volume":"96","author":"Plastaras","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib82","first-page":"12","article-title":"T011: Proton radiotherapy for mediastinal Hodgkin lymphoma: Single institution experience","volume":"101","author":"D\u011bde\u010dkov\u00e1","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib83","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2014.01.041","article-title":"Involved-site image-guided intensity modulated versus 3D conformal radiation therapy in early stage supradiaphragmatic Hodgkin lymphoma","volume":"89","author":"Filippi","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib84","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijrobp.2011.11.008","article-title":"Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement","volume":"84","author":"Lu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.05.004_bib85","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijrobp.2010.09.007","article-title":"Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma","volume":"80","author":"Paumier","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161730901X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161730901X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T17:07:29Z","timestamp":1582564049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161730901X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S036030161730901X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.004","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}